vs
STRATASYS LTD.（SSYS）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
STRATASYS LTD.的季度营收约是再鼎医药的1.1倍（$137.0M vs $127.1M），再鼎医药同比增速更快（17.1% vs -2.2%），STRATASYS LTD.自由现金流更多（$2.5M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs -7.4%）
Stratasys是一家美以合资的增材制造企业，总部注册于以色列，主营聚合物3D打印设备、配套软件与打印材料，同时按需提供3D打印零部件服务。其3D打印方案被工程领域广泛采用，可加工ABS、聚碳酸酯、尼龙12等多种聚合物材料，适配复杂几何构件的建模生产。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
SSYS vs ZLAB — 直观对比
营收规模更大
SSYS
是对方的1.1倍
$127.1M
营收增速更快
ZLAB
高出19.3%
-2.2%
自由现金流更多
SSYS
多$29.2M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
-7.4%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $137.0M | $127.1M |
| 净利润 | $-55.6M | — |
| 毛利率 | 41.0% | 51.0% |
| 营业利润率 | -16.6% | -54.6% |
| 净利率 | -40.6% | — |
| 营收同比 | -2.2% | 17.1% |
| 净利润同比 | -109.0% | — |
| 每股收益（稀释后） | — | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SSYSZLAB
| Q4 25 | — | $127.1M | ||
| Q3 25 | $137.0M | $115.4M | ||
| Q2 25 | $138.1M | $109.1M | ||
| Q1 25 | $136.0M | $105.7M | ||
| Q4 24 | — | $108.5M | ||
| Q3 24 | $140.0M | $101.8M | ||
| Q2 24 | $138.0M | $100.1M | ||
| Q1 24 | $144.1M | $87.1M |
净利润SSYSZLAB
| Q4 25 | — | — | ||
| Q3 25 | $-55.6M | $-36.0M | ||
| Q2 25 | $-16.7M | $-40.7M | ||
| Q1 25 | $-13.1M | $-48.4M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-26.6M | $-41.7M | ||
| Q2 24 | $-25.7M | $-80.3M | ||
| Q1 24 | $-26.0M | $-53.5M |
毛利率SSYSZLAB
| Q4 25 | — | 51.0% | ||
| Q3 25 | 41.0% | 59.5% | ||
| Q2 25 | 43.1% | 60.6% | ||
| Q1 25 | 44.3% | 63.6% | ||
| Q4 24 | — | 61.5% | ||
| Q3 24 | 44.8% | 64.1% | ||
| Q2 24 | 43.8% | 64.9% | ||
| Q1 24 | 44.4% | 61.4% |
营业利润率SSYSZLAB
| Q4 25 | — | -54.6% | ||
| Q3 25 | -16.6% | -42.3% | ||
| Q2 25 | -12.0% | -50.3% | ||
| Q1 25 | -9.1% | -53.3% | ||
| Q4 24 | — | -62.6% | ||
| Q3 24 | -18.2% | -66.6% | ||
| Q2 24 | -18.9% | -76.0% | ||
| Q1 24 | -17.0% | -80.7% |
净利率SSYSZLAB
| Q4 25 | — | — | ||
| Q3 25 | -40.6% | -31.2% | ||
| Q2 25 | -12.1% | -37.3% | ||
| Q1 25 | -9.6% | -45.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | -19.0% | -40.9% | ||
| Q2 24 | -18.6% | -80.2% | ||
| Q1 24 | -18.0% | -61.4% |
每股收益（稀释后）SSYSZLAB
| Q4 25 | — | $-0.05 | ||
| Q3 25 | — | $-0.03 | ||
| Q2 25 | — | $-0.04 | ||
| Q1 25 | — | $-0.04 | ||
| Q4 24 | — | $-0.09 | ||
| Q3 24 | — | $-0.04 | ||
| Q2 24 | — | $-0.08 | ||
| Q1 24 | — | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $71.5M | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $852.5M | $715.5M |
| 总资产 | $1.1B | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资SSYSZLAB
| Q4 25 | — | $689.6M | ||
| Q3 25 | $71.5M | $717.2M | ||
| Q2 25 | $71.1M | $732.2M | ||
| Q1 25 | $70.1M | $757.3M | ||
| Q4 24 | — | $779.7M | ||
| Q3 24 | $64.0M | $616.1M | ||
| Q2 24 | $70.9M | $630.0M | ||
| Q1 24 | $91.1M | $650.8M |
股东权益SSYSZLAB
| Q4 25 | — | $715.5M | ||
| Q3 25 | $852.5M | $759.9M | ||
| Q2 25 | $902.4M | $791.7M | ||
| Q1 25 | $784.8M | $810.8M | ||
| Q4 24 | — | $840.9M | ||
| Q3 24 | $831.8M | $667.7M | ||
| Q2 24 | $850.5M | $704.2M | ||
| Q1 24 | $866.1M | $762.2M |
总资产SSYSZLAB
| Q4 25 | — | $1.2B | ||
| Q3 25 | $1.1B | $1.2B | ||
| Q2 25 | $1.1B | $1.2B | ||
| Q1 25 | $1.0B | $1.2B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | $1.1B | $985.3M | ||
| Q2 24 | $1.1B | $987.4M | ||
| Q1 24 | $1.1B | $988.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $6.9M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $2.5M | $-26.7M |
| 自由现金流率自由现金流/营收 | 1.8% | -21.0% |
| 资本支出强度资本支出/营收 | 3.2% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-11.5M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流SSYSZLAB
| Q4 25 | — | $-26.0M | ||
| Q3 25 | $6.9M | $-32.0M | ||
| Q2 25 | $-1.1M | $-31.0M | ||
| Q1 25 | $4.5M | $-61.7M | ||
| Q4 24 | — | $-55.8M | ||
| Q3 24 | $-4.5M | $-26.8M | ||
| Q2 24 | $-2.4M | $-42.2M | ||
| Q1 24 | $7.3M | $-90.1M |
自由现金流SSYSZLAB
| Q4 25 | — | $-26.7M | ||
| Q3 25 | $2.5M | $-35.0M | ||
| Q2 25 | $-8.4M | $-33.9M | ||
| Q1 25 | $789.0K | $-63.2M | ||
| Q4 24 | — | $-58.4M | ||
| Q3 24 | $-6.3M | $-28.2M | ||
| Q2 24 | $-4.9M | $-42.9M | ||
| Q1 24 | $5.0M | $-91.1M |
自由现金流率SSYSZLAB
| Q4 25 | — | -21.0% | ||
| Q3 25 | 1.8% | -30.4% | ||
| Q2 25 | -6.1% | -31.1% | ||
| Q1 25 | 0.6% | -59.9% | ||
| Q4 24 | — | -53.8% | ||
| Q3 24 | -4.5% | -27.7% | ||
| Q2 24 | -3.6% | -42.9% | ||
| Q1 24 | 3.5% | -104.5% |
资本支出强度SSYSZLAB
| Q4 25 | — | 0.5% | ||
| Q3 25 | 3.2% | 2.6% | ||
| Q2 25 | 5.3% | 2.6% | ||
| Q1 25 | 2.8% | 1.5% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | 1.3% | 1.3% | ||
| Q2 24 | 1.8% | 0.7% | ||
| Q1 24 | 1.6% | 1.1% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
SSYS
暂无分部数据
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
